BALTIMORE and LAUSANNE, Switzerland, Nov. 28, 2018 /PRNewswire/ -- Braintech leader MindMaze has today announced an acquisition that aims to significantly advance recovery for patients suffering from neurological diseases and injuries. The acquisition of Neuro Motor Innovations Corporation (NMI), which combines neuroscience and a novel form of animation - "neuroanimation" - to stimulate vast improvement of cognitive and motor functions, complements MindMaze's current approach to neuro-rehabilitation. MindMaze will further develop and commercialize NMI's technology that targets treatment of a wide range of neurological diseases and injuries from the acute through chronic stages. Additionally, the immersive cognitive-motor experiences can be used for healthy aging and wellness, as it has become apparent that complex movements are essential for maintaining executive cognitive function.
NMI is co-founded by neuroscientist Dr. John Krakauer, computer scientist Dr. Omar Ahmad, and software architect Promit Roy at The Kata Design Studio at The Johns Hopkins University Department of Neurology, and CEO Hoyt David Morgan. MindMaze acquires a perpetual license to NMI's technology, and the company will continue its close relationship with Johns Hopkins. Dr. Krakauer will continue as a Malone Professor at Hopkins' School of Medicine and the Malone Center for Engineering in Healthcare and also serve as Chief Medical and Scientific Advisor to MindMaze.
"It has long been known in the scientific community that enrichment - stimulating the brain by enhancing the physical and social environment - is important for neurological recovery in animal models, but there is no such equivalent in clinical settings for humans," said Dr. Krakauer. "Our vision is to design a new platform that creates an immersive and enriching environment that integrates with existing MindMaze technology to deliver effective movement and cognitive therapy for many neurological diseases and injuries. The goal is to build a universal platform that can accelerate brain repair."
MindMaze has created the first version of a global clinic-to-patient platform for neurological therapy, which uses an intuitive mind/machine interface to instantly decode brain and muscle signals. Powered by neuroscience, mixed reality, and artificial intelligence, MindMaze's platform is used and proven across multiple industries. The company started in the healthcare industry, its MindMotion™ PRO, being the first neuro-rehabilitation solution to be FDA-cleared for patients in the United States. NMI will now work to create the next version of this platform.
"This acquisition of the Neuro Motor Innovations technology and the team is a very significant deal for MindMaze and one that offers huge promise for patients with neurological diseases and injuries," said Tej Tadi, Founder, and CEO of MindMaze. "The integration of NMI's technology into our platform creates the first multi-stage platform for neurological therapy."
About MindMaze
MindMaze is the world leader in brain technology. The end-to-end MindMaze Braintech Platform uniquely captures brain activity and intent and is able to use this understanding for real-time therapeutic, interactive, and immersive solutions. Based on more than a decade of rigorous testing in the healthcare industry, the company's innovations are transforming industries that include: medical, entertainment, automotive and gaming.
MindMaze has raised $109 million from global investors. It is founded by Tej Tadi, PhD, with U.S. headquarters in San Francisco, and European headquarters in Lausanne, Switzerland. For more information, please visit: www.mindmaze.com.
About Neuro Motor Innovations (NMI)
NMI is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients across the world. NMI's immersive therapy experiences are designed to be the core of a universal brain repair platform and combine unique cognitive and motor explorations that engender dynamic and continuous patient movement. For more information, please visit: www.neuromotorinnovations.com.
Media Contact
Consort Partners for MindMaze: [email protected]
Advertisement
NMI is co-founded by neuroscientist Dr. John Krakauer, computer scientist Dr. Omar Ahmad, and software architect Promit Roy at The Kata Design Studio at The Johns Hopkins University Department of Neurology, and CEO Hoyt David Morgan. MindMaze acquires a perpetual license to NMI's technology, and the company will continue its close relationship with Johns Hopkins. Dr. Krakauer will continue as a Malone Professor at Hopkins' School of Medicine and the Malone Center for Engineering in Healthcare and also serve as Chief Medical and Scientific Advisor to MindMaze.
Advertisement
"It has long been known in the scientific community that enrichment - stimulating the brain by enhancing the physical and social environment - is important for neurological recovery in animal models, but there is no such equivalent in clinical settings for humans," said Dr. Krakauer. "Our vision is to design a new platform that creates an immersive and enriching environment that integrates with existing MindMaze technology to deliver effective movement and cognitive therapy for many neurological diseases and injuries. The goal is to build a universal platform that can accelerate brain repair."
MindMaze has created the first version of a global clinic-to-patient platform for neurological therapy, which uses an intuitive mind/machine interface to instantly decode brain and muscle signals. Powered by neuroscience, mixed reality, and artificial intelligence, MindMaze's platform is used and proven across multiple industries. The company started in the healthcare industry, its MindMotion™ PRO, being the first neuro-rehabilitation solution to be FDA-cleared for patients in the United States. NMI will now work to create the next version of this platform.
"This acquisition of the Neuro Motor Innovations technology and the team is a very significant deal for MindMaze and one that offers huge promise for patients with neurological diseases and injuries," said Tej Tadi, Founder, and CEO of MindMaze. "The integration of NMI's technology into our platform creates the first multi-stage platform for neurological therapy."
About MindMaze
MindMaze is the world leader in brain technology. The end-to-end MindMaze Braintech Platform uniquely captures brain activity and intent and is able to use this understanding for real-time therapeutic, interactive, and immersive solutions. Based on more than a decade of rigorous testing in the healthcare industry, the company's innovations are transforming industries that include: medical, entertainment, automotive and gaming.
MindMaze has raised $109 million from global investors. It is founded by Tej Tadi, PhD, with U.S. headquarters in San Francisco, and European headquarters in Lausanne, Switzerland. For more information, please visit: www.mindmaze.com.
About Neuro Motor Innovations (NMI)
NMI is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients across the world. NMI's immersive therapy experiences are designed to be the core of a universal brain repair platform and combine unique cognitive and motor explorations that engender dynamic and continuous patient movement. For more information, please visit: www.neuromotorinnovations.com.
Media Contact
Consort Partners for MindMaze: [email protected]
View original content:http://www.prnewswire.com/news-releases/mindmaze-acquires-nmi-300754290.html
SOURCE MindMaze
